Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of federal and state laws by Walgreens Boots Alliance, Inc. (NASDAQ: WBA) and certain of its officers. Walgreens operates a network of drugstores in the United States.
On August 4, 2014, Walgreens announced that Wade Miquelon, the Company’s Chief Financial Officer, would be resigning. Two days later, on August 6, 2014, Walgreens disclosed that it would be lowering the FY 2016 EBIT forecast to $7.2 billion, $1.8 billion below the low-end and $2.3 billion below the high-end of the range that they had repeatedly touted to investors. On the news, Walgreens’ share price plummeted, dropping from a close of $69.12 on August 5, 2014 to a close of $59.21 on August 6, 2014, a drop of over 14% on massive volume.
Specifically, Johnson & Weaver’s investigation seeks to determine whether certain statements regarding Walgreens’ business and prospects were false and misleading when made.
If you have information that could assist in this investigation, or if you are a Walgreens shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Contacts:
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
